Agent for the treatment of herpes virus-derived pain

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/185 (2006.01) A61K 45/00 (2006.01) A61P 25/02 (2006.01) A61P 29/00 (2006.01) A61P 31/22 (2006.01)

Patent

CA 2613030

The present invention is in the field of treatment of pain caused by the herpes virus. The invention provides a therapeutic agent for the treatment of herpes virus-derived pain which comprises (\)-[2-[4-(3-ethoxy-2-hydroxy- propoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate represented by the formula (1) as the active ingredient. (see formula 1)

La présente invention décrit un agent thérapeutique dérivé de l'herpèsvirus et destiné à lutter contre la douleur qui comprend du p-toluènesulfonate de (±)-[2-[4-(3-éthoxy-2-hydroxypropoxy)phénylcarbamoyl]éthyl]diméthylsulfonium de formule (1) au titre de principe actif. [Formule chimique] (1)

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Agent for the treatment of herpes virus-derived pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for the treatment of herpes virus-derived pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for the treatment of herpes virus-derived pain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2078807

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.